Skip to content
Agentic OS
Menu

Intelligence / Healthtech / De Novo Grants / Bridge TO Life, Ltd.

Approvalsnovel device granted (FDA De Novo)15 Jan 2026

Bridge TO Life, Ltd.

15 Jan 2026: Novel device granted (FDA De Novo) · VitaSmart Hypothermic Oxygenated Perfusion System. Recorded in the openFDA device 510(k) (De Novo decisions).

View the source record

Granted
15 Jan 2026
Device
VitaSmart Hypothermic Oxygenated Perfusion System
Specialty
Gastroenterology, Urology
Product Code
SGY
Country
United States
Location
Northbrook, IL
Submitted
2025-03-31
Reference
DEN250009
What this signal means

A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.

  1. 2 added in the 30 days to 19 Nov 2026.
  2. Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS

Find the decision makers at Bridge TO Life, Ltd.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

More in Gastroenterology, Urology

De Novo Grants

See all

Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.